Literature DB >> 1337181

Natural history, clinical course and morphological evolution of membranous nephropathy.

E Honkanen1, T Törnroth, C Grönhagen-Riska.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1337181

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  8 in total

1.  Long-term outcomes of initial therapy for idiopathic membranous nephropathy.

Authors:  Masayo Sato; Takashi Takei; Takahito Moriyama; Mitsuyo Itabashi; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2016-12-20       Impact factor: 2.801

2.  The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.

Authors:  Ji Young Choi; Dong Ki Kim; Yang Wook Kim; Tae Hyun Yoo; Jung Pyo Lee; Hyun Chul Chung; Kyu Hyang Cho; Won Suk An; Duk Hyun Lee; Hee Yeon Jung; Jang Hee Cho; Chan Duck Kim; Yong Lim Kim; Sun Hee Park
Journal:  J Korean Med Sci       Date:  2018-02-26       Impact factor: 2.153

3.  Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy.

Authors:  Yaeni Kim; Hye Eun Yoon; Byung Ha Chung; Bum Soon Choi; Cheol Whee Park; Chul Woo Yang; Yong-Soo Kim; Yu Ah Hong; Suk Young Kim; Yoon-Kyung Chang; Hyeon Seok Hwang
Journal:  Korean J Intern Med       Date:  2019-08-14       Impact factor: 2.884

4.  Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.

Authors:  Guoqiang Xie; Jing Xu; Chaoyang Ye; Dongping Chen; Chenggang Xu; Li Yang; Yiyi Ma; Xiaohong Hu; Lin Li; Lijun Sun; Xuezhi Zhao; Zhiguo Mao; Changlin Mei
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

5.  Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study.

Authors:  Shanshan Liu; Xiayu Li; Heng Li; Qian Liang; Jun Chen; Jianghua Chen
Journal:  BMC Nephrol       Date:  2015-12-04       Impact factor: 2.388

6.  Circulating TNF receptors are significant prognostic biomarkers for idiopathic membranous nephropathy.

Authors:  Su Mi Lee; SeungHee Yang; Ran-Hui Cha; Myounghee Kim; Jung Nam An; Jin Ho Paik; Dong Ki Kim; Shin-Wook Kang; Chun Soo Lim; Yon Su Kim; Jung Pyo Lee
Journal:  PLoS One       Date:  2014-08-06       Impact factor: 3.240

7.  Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.

Authors:  Dan Zhang; Jun Zou; Chong Zhang; Wenzhu Zhang; Fujun Lin; Gengru Jiang
Journal:  Med Sci Monit       Date:  2018-07-22

8.  Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy.

Authors:  Yaling Guo; Xueping Wu; Lei Liu; Haifeng Zhang; Lijuan Yang; Weidong Chen
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.